Overview
Status
Active
Registry date
2019-05-27
Share capital
10,000.00 PLN
Registered address
ul. Mieczysława Pożaryskiego 28, 04-703 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Piotr Bokszczanin – President of the Management Board
Daniel Gralak – Management Board Member
Elwira Maria Haak – Management Board Member
Manner of representation
Joint action by two members of the management board is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jan Bokszczaninage 75 | 26 | $702.32 | 26% |
Maria Bokszczaninage 66 | 25 | $675.31 | 25% |
| 49 | $1,323.61 | 49% |
Jan Bokszczanin and Maria Bokszczanin hold a combined 51% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Sep 15, 2026 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2019-08-12 | Address change (Ul. Leona Kruczkowskiego 8, 00-380, Warszawa → Ul. Mieczysława Pożaryskiego 28, 04-703, Warszawa) | |
| 2019-05-27 | Entered in the register |
FAQ
The main business activity of Anafea focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on May 27, 2019.
The headquarters is located at: ul. Mieczysława Pożaryskiego 28, 04-703 Warszawa.
The management board includes Daniel Gralak (Member of the Management Board).
The share capital of the company is PLN 10,000 (approx. $2,701).
Last updated: 2026-04-13